Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer: A Meta-analysis and Individual Patient–Level Analysis

IMPORTANCE: The beneficial role of immunotherapy and the clinical relevance of current biomarkers in non–small cell lung cancer (NSCLC) remain inconclusive; thus, appropriate strategies and reliable predictors need further definition. OBJECTIVES: To evaluate the association of clinical outcomes with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yunfang, Zeng, Dongqiang, Ou, Qiyun, Liu, Shengbo, Li, Anlin, Chen, Yongjian, Lin, Dagui, Gao, Quanlong, Zhou, Haiyu, Liao, Wangjun, Yao, Herui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625073/
https://www.ncbi.nlm.nih.gov/pubmed/31290993
http://dx.doi.org/10.1001/jamanetworkopen.2019.6879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625073/
https://www.ncbi.nlm.nih.gov/pubmed/31290993
http://dx.doi.org/10.1001/jamanetworkopen.2019.6879

Ejemplares similares